Penta Foundation
Clinical trials sponsored by Penta Foundation, explained in plain language.
-
Simpler HIV treatment for kids tested in global trial
Disease control OngoingThis study is testing whether a two-drug HIV treatment (dolutegravir/lamivudine) is as safe and effective as standard three-drug treatments for children aged 2-15 who already have their virus under control. About 370 children will be randomly assigned to either continue their cur…
Phase: PHASE2, PHASE3 • Sponsor: PENTA Foundation • Aim: Disease control
Last updated Apr 01, 2026 14:42 UTC
-
New hope for kids with HIV: Easier-to-Take medicine in testing
Disease control TerminatedThis study aimed to test a new, child-friendly tablet version of an existing HIV medicine (darunavir/ritonavir) for children aged 3 and older. The goal was to find the right dose, check if it was safe, and see if kids could take it easily. The trial was designed to enroll childre…
Phase: PHASE1, PHASE2 • Sponsor: PENTA Foundation • Aim: Disease control
Last updated Mar 27, 2026 12:39 UTC
-
New hope for kids battling Drug-Resistant HIV
Disease control OngoingThis study is testing a drug called fostemsavir, combined with other optimized HIV medications, in children and adolescents (ages 6 to 18) whose current HIV treatments are failing because the virus has become resistant to multiple drugs. The main goals are to see if this new comb…
Phase: PHASE1, PHASE2 • Sponsor: PENTA Foundation • Aim: Disease control
Last updated Mar 27, 2026 12:38 UTC